CRISPRi Screening Identifies SON and MAP4K1 as Regulators of Type III Cytokine Expression in Innate Lymphoid Cells
Rachel Anne Brown, Andrew W. Dangel, Ankita Saini, Patrick L. Collins, Marco Colonna, Eugene M. Oltz
A CRISPRi screen identifies SON and MAP4K1 as regulators of IL-22 and IL-17 expression in innate lymphoid cells, revealing new therapeutic targets for immune-mediated diseases.
The Journal of Immunology · Jun 1, 2026Peer-reviewedImmunology